SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fitch Ratings affirms Claris Lifesciences long-term rating

12 Mar 2012 Evaluate

Credit rating agency, Fitch Ratings has affirmed India-based Claris Lifesciences’ National Long-Term rating at ‘Fitch A-(ind) 1’ with a stable outlook. The affirmed ratings reflect the company’s comfortable credit metrics.

Claris Lifesciences’ consolidated net profit has declined by 10.70% to Rs 126.26 crore for FY11 from Rs 141.44 crore in the previous year. The company’s consolidated net sales also declined by 1.8% to Rs 738.76 crore from Rs 752.33 crore. Its earnings per share declined to Rs 19.78 from Rs 27.34 in the last year.

Peers
Company Name CMP
Redington 280.90
Amrapali Industries 42.31
Adani Enterprises 3037.90
Rashi Peripheral 752.80
PDS 338.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: